Rigaku Corporation Acquires MILabs B.V.
August 2, 2021
Rigaku Corporation acquired all issued shares of MILabs B.V., a Netherlands-based manufacturer of preclinical PET, SPECT, CT and optical imaging systems, closing on August 2, 2021. The deal expands Rigaku's entry into the life sciences and pre-clinical imaging market by combining MILabs' multi-modality imaging capabilities with Rigaku's X-ray imaging and global sales and service network.
- Buyers
- Rigaku Corporation
- Targets
- MILabs B.V.
- Industry
- Medical Devices
- Location
- Utrecht, Netherlands
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Bruker Corporation Acquires Spectral Instruments Imaging
February 6, 2024
Medical Devices
Bruker Corporation has acquired Spectral Instruments Imaging LLC, a Tucson-based maker of preclinical in‑vivo optical imaging systems, to broaden Bruker BioSpin's preclinical imaging portfolio. Financial terms were not disclosed; SII generated over $10 million in revenue in 2023 and will expand Bruker's capabilities in bioluminescence, fluorescence and X‑ray preclinical imaging.
-
Calibre Scientific Acquires Labtech International Ltd
January 17, 2024
Medical Devices
Calibre Scientific has acquired Labtech International Ltd, a UK-based supplier and service provider of life science instruments, microscopy equipment, consumables and technical services. The acquisition expands Calibre Scientific's analytical instrument and service capabilities across the British Isles, strengthening its product offering and local service footprint for customers in biotechnology, diagnostics, education, environmental and pharmaceutical markets.
-
L2P Research Acquires METIS Research Laboratories
February 28, 2020
Biotechnology
L2P Research, LLC has acquired METIS Research Laboratories, a Ronkonkoma, New York-based preclinical CRO that provides radiotracer, radioligand binding, ADME/PK and QWBA services. The acquisition adds a GLP-compliant 5,000 sq. ft. facility and expands L2P's preclinical capabilities for pharma, biotech and academic customers.
-
Miltenyi Biotec Acquires lino Biotech
March 22, 2023
Biotechnology
Miltenyi Biotec has acquired 100% of lino Biotech from investors including Roche Venture Fund and Hightech-Grunderfonds. The acquisition brings lino's focal molography biosensor platform into Miltenyi's cell and gene therapy and research-tools portfolio to enhance potency assays and quality-control capabilities.
-
Lantheus Acquires Life Molecular Imaging (Life Molecular) for $350M Upfront
July 22, 2025
Healthcare Services
Lantheus Holdings completed its previously announced acquisition of Life Molecular Imaging Ltd., a subsidiary of Life Healthcare Group Holdings Ltd. The deal includes an upfront payment of $350 million and (per the earlier definitive agreement) up to $400 million in potential earn-out and milestone payments, and strengthens Lantheus’s commercial and R&D capabilities in Alzheimer’s PET diagnostics with Neuraceq (florbetaben F18).
-
Waters Corporation Acquires Halo Labs
May 21, 2025
Medical Devices
Waters Corporation has acquired Halo Labs, a venture-backed developer of the Aura imaging platform for subvisible and visible particle analysis used in cell, gene and protein therapy development and QA/QC. The deal brings Halo Labs' high-throughput, low-volume particle analysis technology into Waters' Wyatt Technology portfolio to expand Waters' analytical and bioprocessing testing capabilities for large-molecule therapies.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.